Clinical Trials Browser

Unknown × OTHER × Solid Tumor × Clear all

NCT05576961 2024-01-23

Safety and Efficacy of RX-af01 Combined With PD-1 Antibody

Phase 1/2 Unknown

Other solid neoplasm

Solid Tumor

NCT05322512 2023-11-29

Nectin-4 Targeting ADC Probe for PET Imaging in Solid Tumors

Phase NA Unknown

Other solid neoplasm

Solid Tumor

NCT06022276 2023-09-01

Nimotuzumab for EGFR-amplified Advanced Pan Solid Tumors

Phase NA Unknown

Other solid neoplasm

Solid Tumor

NCT06022289 2023-09-01

Pemigatinib for FGF/FGFR Alterations Advanced Pan Solid Tumors

Phase 2 Unknown

Other solid neoplasm

Solid Tumor

NCT05940181 2023-07-11

A Safety and Efficacy Study of XH001 Combined With Sintilimab Injection in Advanced Solid Tumors

Phase NA Unknown

Other solid neoplasm

Solid Tumor

NCT05359354 2023-05-16

Safety and Efficacy of Personalized Neoantigen Vaccine in Advanced Solid Tumors

Phase NA Unknown

Other solid neoplasm

Solid Tumor

NCT05833984 2023-04-27

Safety and Efficacy of IMM01 Plus Tislelizumab in Patients With Advanced Solid Tumors and Lymphomas

Phase 1/2 Unknown

LymphoidOther solid neoplasm

Solid Tumor

NCT04542863 2023-03-29

The Molecular Imaging Research of F-18 Labeled DX600 PET Probe

Phase NA Unknown

Other solid neoplasm

Solid Tumor

NCT04214717 2023-03-28

DC-CIK

Phase NA Unknown

Other solid neoplasm

Solid Tumor

NCT04214730 2023-03-28

NK

Phase NA Unknown

Other solid neoplasm

Solid Tumor

NCT05748938 2023-03-01

A Study of RD14-01 in Patients With Advanced Solid Tumors

Phase 1/2 Unknown

Other solid neoplasm

Solid Tumor

NCT05745454 2023-02-27

A Clinical Study on the Safety and Efficacy of Chimeric Antigen Receptor T-cell (CART) in the Treatment of Solid Tumors

Phase NA Unknown

Other solid neoplasm

Solid Tumor

NCT05724732 2023-02-13

Exploratory Clinical Study of Autologous Tumor-infiltrating Lymphocyte Injection (GT201) for Advanced Gynecologic Tumors

Phase EARLY_PHASE1 Unknown

Other solid neoplasm

Solid Tumor

NCT05638828 2022-12-06

A Study of RD14-01 in Patients With Advanced Solid Tumors

Phase EARLY_PHASE1 Unknown

Other solid neoplasm

Solid Tumor

NCT05373147 2022-10-26

αPD1-MSLN-CAR T Cells for the Treatment of MSLN-positive Advanced Solid Tumors

Phase EARLY_PHASE1 Unknown

Other solid neoplasm

Solid Tumor

NCT05512780 2022-08-23

Dalpiciclib Combined With Letrozole in Neoadjuvant Treatment of Stage Ⅱ-Ⅲ HR-positive/HER2-negative Breast Cancer

Phase 2 Unknown

Other solid neoplasm

Solid Tumor

NCT04407897 2022-04-28

SOFT

Phase NA Unknown

Other solid neoplasm

Solid Tumor

NCT05284968 2022-03-17

RD07 Cell Injection in the Treatment of Patients With Advanced Claudin18.2 Positive Solid Tumors

Phase EARLY_PHASE1 Unknown

Other solid neoplasm

Solid Tumor

NCT05274191 2022-03-10

An Exploratory Basket Study of Pyrotinib Maleate Tablets in HER2 Mutated or Amplified of Metastatic Solid Tumors

Phase 2 Unknown

Other solid neoplasm

Solid Tumor

NCT05246995 2022-02-18

A Phase I Study of IBI325 in Patients With Advanced Solid Tumor

Phase 1 Unknown

Other solid neoplasm

Solid Tumor

NCT05136937 2022-01-31

A Clinical Study of Intratumoral Administration of RT-01 in Patients With Advanced Solid Tumors

Phase 1 Unknown

Other solid neoplasm

Solid Tumor

NCT05097781 2021-10-28

Local Radiotherapy in Combination With Immunotherapy in Advanced Solid Tumors Patients

Phase 2 Unknown

Other solid neoplasm

Solid Tumor

NCT04569916 2020-09-30

Radiotherapy Combined With Irinotecan and Apatinib Followed by PD-1 Antibody and Apatinib for Advanced Solid Tumors

Phase 2 Unknown

Other solid neoplasm

Solid Tumor

NCT04432649 2020-06-16

Targeting CD276 (B7-H3) Positive Solid Tumors by 4SCAR-276

Phase 1/2 Unknown

Other solid neoplasm

Solid Tumor

NCT04360317 2020-04-24

Safety of the Combination of SH003 and Docetaxel in Patients With Solid Cancer

Phase 1 Unknown

Other solid neoplasm

Solid Tumor

NCT04300088 2020-03-09

GEIA

Other solid neoplasm

Solid Tumor

NCT04179656 2019-11-27

The Basket Study of Pyrotinib Maleate for HER2-Postive Solid Tumor

Phase 2 Unknown

Other solid neoplasm

Solid Tumor

NCT03879057 2019-10-01

Trial of Surufatinib Combined With JS001 in the Treatment of Advanced Solid Tumors

Phase 1 Unknown

Other solid neoplasm

Solid Tumor

NCT03596593 2018-07-24

IMPACT

Phase NA Unknown

Other solid neoplasm

Solid Tumor

NCT01929486 2016-02-17

Phase Ia/Ib Multicenter Trial of Mogamulizumab for Advanced or Recurrent Cancer.

Phase 1 Unknown

Other solid neoplasm

Solid Tumor

NCT02255292 2014-10-02

A Study: Pure CBD as Single-agent for Solid Tumor.

Phase 2 Unknown

Other solid neoplasm

Solid Tumor